Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Finish Line Q4 Profit Grows - Quick Facts

RELATED NEWS
Trade FINL now with 

Finish Line Inc. (FINL: Quote) posted higher fourth-quarter net income of $41.92 million or $0.80 per share compared with $34.25 million or $0.63 per share last year.

On a non-GAAP basis, net profit improved to $42.52 million or $0.81 per share from the prior-year quarter's $35.02 million or $0.65 per share. On average, 12 analysts polled by Thomson Reuters expected earnings per share of $0.81 for the quarter. Analysts' estimates typically exclude one-time items.

Consolidated net sales, inclusive of Finish Line and The Running Company, rose 18.6% to $456.3 million from $384.6 million in the earlier year quarter. Ten analysts estimated revenues of $432.62 million for the quarter.

Click here to receive FREE breaking news email alerts for Finish Line Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.